Andreas Busch
Corporate Officer/Principal at ABSCI CORPORATION
Net worth: - $ as of 29/04/2024
Andreas Busch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABSCI CORPORATION | Corporate Officer/Principal | 03/10/2022 | - |
| Director/Board Member | 16/03/2022 | 03/10/2022 |
Career history of Andreas Busch
Former positions of Andreas Busch
| Companies | Position | Start | End |
|---|---|---|---|
| CENTOGENE N.V. | Director/Board Member | 17/02/2022 | 11/12/2023 |
| CYCLERION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2020 | 29/09/2022 |
| Corporate Officer/Principal | 28/04/2019 | 31/12/2020 | |
| SHIRE | Chief Tech/Sci/R&D Officer | 31/12/2017 | 28/02/2019 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 31/12/2015 | 30/11/2017 |
| Aventis Pharma AG | Corporate Officer/Principal | 31/12/2004 | 31/12/2004 |
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Corporate Officer/Principal | 31/12/1996 | 31/12/2004 |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | 31/12/1996 | 31/12/1998 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Director/Board Member | - | - |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Andreas Busch
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Statistics
International
| Germany | 7 |
| United States | 4 |
| Ireland | 2 |
Operational
| Corporate Officer/Principal | 8 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 6 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ABSCI CORPORATION | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| CENTOGENE N.V. | Commercial Services |
| Private companies | 7 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
| Aventis Pharma AG | |
| Hoechst Marion Roussel, Inc. | |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Sanofi-Aventis Groupe SA
Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Finance |
- Stock Market
- Insiders
- Andreas Busch
- Experience
